| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 9 | -3,785,179 | 100% | $15.34 | -$58,060,377 |
| Net | -9 | -3,785,179 | -100% | -$58,060,377 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Chad M. Robins | CEO and Chairman, Director | $30,305,658 | -$23,152,321 | -43% | 11 Mar 2026 |
| Harlan S. Robins | Chief Scientific Officer | $20,045,503 | -$8,888,063 | -31% | 11 Mar 2026 |
| Julie Rubinstein | President and COO | $6,582,824 | -$5,079,223 | -44% | 11 Mar 2026 |
| Susan Bobulsky | Chief Commercial Officer, MRD | $5,633,796 | -$544,421 | -8.8% | 11 Mar 2026 |
| Francis Lo | Chief People Officer | $4,142,195 | -$4,316,829 | -51% | 11 Mar 2026 |
| Peter M. Neupert | Director | $3,811,395 | 04 Mar 2026 | ||
| Sharon Benzeno | Chief Commercial Ofc Imm Med | $3,592,130 | -$11,187,469 | -76% | 11 Mar 2026 |
| Kyle Piskel | Chief Financial Officer | $3,422,092 | -$3,575,358 | -51% | 11 Mar 2026 |
| Tycho Peterson | Chief Financial Officer | $1,828,542 | 04 Mar 2024 | ||
| Katey Einterz Owen | Director | $1,399,708 | 04 Mar 2026 | ||
| Robert Hershberg | Director | $988,823 | -$367,488 | -27% | 04 Mar 2026 |
| Nitin Sood | Chief Commercial Officer, MRD | $887,157 | 07 Aug 2023 | ||
| R. Mark Adams | Chief Operating Officer | $724,241 | 10 Apr 2023 | ||
| Stacy L. Taylor | SVP and General Counsel | $626,780 | 22 Aug 2024 | ||
| Michael J. Pellini | Director | $553,339 | 04 Mar 2025 | ||
| Michelle Renee Griffin | Director | $217,343 | -$949,204 | -81% | 11 Mar 2026 |
| Henning Thorsen | SVP, Commercial Operations | $120,022 | 17 May 2021 | ||
| Leslie L. Trigg | Director | $106,996 | 06 Mar 2023 | ||
| Conroy Kevin T. | Director | $94,858 | 06 Mar 2023 | ||
| Chad M. Cohen | Chief Financial Officer | $89,225 | 22 Dec 2021 | ||
| Lance Baldo | Chief Medical Officer | $70,916 | 08 Mar 2022 | ||
| Jyoti Palaniappan | SVP, Diagnostics, T-Detect | $37,823 | 19 Jul 2021 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Julie Rubinstein | ADPT | Common Stock | Sale | -3.62% | $247,018 | $12.96 | -19,060 | 507,934 | 13 Mar 2026 | Direct |
| Julie Rubinstein | ADPT | Common Stock | Options Exercise | 2.87% | 14,722 | 526,994 | 13 Mar 2026 | Direct | ||
| Julie Rubinstein | ADPT | Stock Option (right to buy) | Options Exercise | -19% | -14,722 | 62,827 | 13 Mar 2026 | Direct | ||
| Julie Rubinstein | ADPT | Common Stock | Sale | -3.59% | $245,048 | $12.86 | -19,060 | 512,272 | 12 Mar 2026 | Direct |
| Julie Rubinstein | ADPT | Common Stock | Options Exercise | 2.85% | 14,722 | 531,332 | 12 Mar 2026 | Direct | ||
| Julie Rubinstein | ADPT | Stock Option (right to buy) | Options Exercise | -16% | -14,722 | 77,549 | 12 Mar 2026 | Direct | ||
| Julie Rubinstein | ADPT | Common Stock | Options Exercise | 2.83% | 14,722 | 535,670 | 11 Mar 2026 | Direct | ||
| Julie Rubinstein | ADPT | Common Stock | Sale | -21.5% | $1,881,993 | $13.29 | -141,583 | 516,610 | 11 Mar 2026 | Direct |
| Julie Rubinstein | ADPT | Stock Option (right to buy) | Options Exercise | -13.8% | -14,722 | 92,271 | 11 Mar 2026 | Direct | ||
| Michelle Renee Griffin | ADPT | Common Stock | Sale | -49.6% | $214,131 | $13.91 | -15,394 | 15,625 | 11 Mar 2026 | Direct |
| Francis Lo | ADPT | Common Stock | Sale | -9.5% | $430,749 | $14.08 | -30,593 | 291,374 | 11 Mar 2026 | Direct |
| Susan Bobulsky | ADPT | Common Stock | Sale | -8.81% | $544,421 | $13.17 | -41,338 | 427,775 | 11 Mar 2026 | Direct |
| Sharon Benzeno | ADPT | Common Stock | Sale | -18.8% | $831,067 | $13.17 | -63,103 | 272,751 | 11 Mar 2026 | Direct |
| Kyle Piskel | ADPT | Common Stock | Sale | -6.7% | $245,910 | $13.17 | -18,672 | 259,840 | 11 Mar 2026 | Direct |
| Harlan S. Robins | ADPT | Common Stock | Sale | -23.6% | $6,193,403 | $13.17 | -470,266 | 1,522,058 | 11 Mar 2026 | Direct |
| Chad M. Robins | ADPT | Common Stock | Sale | -17% | $6,192,099 | $13.17 | -470,167 | 2,301,113 | 11 Mar 2026 | Direct |
| Julie Rubinstein | ADPT | Common Stock | Sale | -2.94% | $285,673 | $14.68 | -19,460 | 643,471 | 10 Mar 2026 | Direct |
| Julie Rubinstein | ADPT | Common Stock | Options Exercise | 2.33% | 15,122 | 662,931 | 10 Mar 2026 | Direct | ||
| Julie Rubinstein | ADPT | Stock Option (right to buy) | Options Exercise | -12.4% | -15,122 | 106,993 | 10 Mar 2026 | Direct | ||
| Julie Rubinstein | ADPT | Common Stock | Sale | -4.56% | $457,617 | $14.79 | -30,941 | 647,809 | 09 Mar 2026 | Direct |
| Julie Rubinstein | ADPT | Common Stock | Options Exercise | 4.08% | 26,603 | 678,750 | 09 Mar 2026 | Direct | ||
| Julie Rubinstein | ADPT | Stock Option (right to buy) | Options Exercise | -17.9% | -26,603 | 121,715 | 09 Mar 2026 | Direct | ||
| Julie Rubinstein | ADPT | Common Stock | Sale | -4.53% | $468,447 | $15.14 | -30,941 | 652,147 | 06 Mar 2026 | Direct |
| Julie Rubinstein | ADPT | Common Stock | Options Exercise | 4.05% | 26,603 | 683,088 | 06 Mar 2026 | Direct | ||
| Julie Rubinstein | ADPT | Stock Option (right to buy) | Options Exercise | -16.3% | -26,603 | 136,437 | 06 Mar 2026 | Direct | ||
| Harlan S. Robins | ADPT | Common Stock | Award | 55.3% | 709,220 | 1,992,324 | 06 Mar 2026 | Direct | ||
| Chad M. Robins | ADPT | Common Stock | Award | 34.4% | 709,220 | 2,771,280 | 06 Mar 2026 | Direct | ||
| Francis Lo | ADPT | Common Stock | Sale | -10.6% | $574,537 | $15.09 | -38,074 | 321,967 | 05 Mar 2026 | Direct |
| Julie Rubinstein | ADPT | Common Stock | Sale | -5.1% | $495,056 | $16.00 | -30,941 | 575,235 | 05 Mar 2026 | Direct |
| Julie Rubinstein | ADPT | Common Stock | Options Exercise | 4.59% | 26,603 | 606,176 | 05 Mar 2026 | Direct | ||
| Julie Rubinstein | ADPT | Stock Option (right to buy) | Options Exercise | -15% | -26,603 | 151,159 | 05 Mar 2026 | Direct | ||
| Peter M. Neupert | ADPT | Common Stock | Award | 6.95% | 15,625 | 240,315 | 04 Mar 2026 | Direct | ||
| Robert Hershberg | ADPT | Common Stock | Award | 33.4% | 15,625 | 62,347 | 04 Mar 2026 | Direct | ||
| Francis Lo | ADPT | Common Stock | Award | 13.9% | 44,063 | 360,041 | 04 Mar 2026 | Direct | ||
| Susan Bobulsky | ADPT | Common Stock | Award | 35.1% | 121,875 | 469,113 | 04 Mar 2026 | Direct | ||
| Sharon Benzeno | ADPT | Common Stock | Award | 13.2% | 39,063 | 335,854 | 04 Mar 2026 | Direct | ||
| Julie Rubinstein | ADPT | Common Stock | Award | 14.1% | 81,250 | 656,485 | 04 Mar 2026 | Direct | ||
| Harlan S. Robins | ADPT | Common Stock | Award | 11.1% | 127,813 | 1,283,104 | 04 Mar 2026 | Direct | ||
| Kyle Piskel | ADPT | Common Stock | Award | 28.6% | 61,875 | 278,512 | 04 Mar 2026 | Direct | ||
| Katey Einterz Owen | ADPT | Common Stock | Award | 21.5% | 15,625 | 88,254 | 04 Mar 2026 | Direct | ||
| Michelle Renee Griffin | ADPT | Common Stock | Award | 101.5% | 15,625 | 31,019 | 04 Mar 2026 | Direct | ||
| Chad M. Robins | ADPT | Common Stock | Award | 6.61% | 127,813 | 2,062,060 | 04 Mar 2026 | Direct | ||
| Julie Rubinstein | ADPT | Common Stock | Sale | -5.07% | $513,621 | $16.60 | -30,941 | 579,573 | 04 Mar 2026 | Direct |
| Julie Rubinstein | ADPT | Common Stock | Options Exercise | 4.56% | 26,603 | 610,514 | 04 Mar 2026 | Direct | ||
| Julie Rubinstein | ADPT | Stock Option (right to buy) | Options Exercise | -13.8% | -26,603 | 165,881 | 04 Mar 2026 | Direct | ||
| Michelle Renee Griffin | ADPT | Common Stock | Sale | -75.7% | $735,073 | $15.30 | -48,044 | 15,394 | 03 Mar 2026 | Direct |
| Michelle Renee Griffin | ADPT | Common Stock | Options Exercise | 312.1% | 48,044 | 63,438 | 03 Mar 2026 | Direct | ||
| Michelle Renee Griffin | ADPT | Stock Option (right to buy) | Options Exercise | -100% | -48,044 | 0 | 03 Mar 2026 | Direct | ||
| Julie Rubinstein | ADPT | Common Stock | Sale | -5.03% | $484,751 | $15.67 | -30,941 | 583,911 | 03 Mar 2026 | Direct |
| Julie Rubinstein | ADPT | Common Stock | Options Exercise | 4.52% | 26,603 | 614,852 | 03 Mar 2026 | Direct |